Neuroinflammation after neonatal hypoxia–ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult

[1]  H. Bergmeyer.  Methods of Enzymatic Analysis , 2019 .

[2]  N. Cheong,et al.  Antioxidant Protects against Increases in Low Molecular Weight Hyaluronan and Inflammation in Asphyxiated Newborn Pigs Resuscitated with 100% Oxygen , 2012, PloS one.

[3]  M. B. Moretto,et al.  Assessment of uric acid and lipid peroxidation in serum and urine after hypoxia–ischemia neonatal in rats , 2011, Neurological Sciences.

[4]  S. Andrade,et al.  Metformin inhibits inflammatory angiogenesis in a murine sponge model. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  M. B. Moretto,et al.  Adenosine deaminase activity, lipid peroxidation and astrocyte responses in the cerebral cortex of rats after neonatal hypoxia ischemia , 2009, International Journal of Developmental Neuroscience.

[6]  N. Dale,et al.  Release of Adenosine and ATP During Ischemia and Epilepsy , 2009, Current neuropharmacology.

[7]  F. Sellke,et al.  N-acetyl-B-D-glucosaminidase and inflammatory response after cardiopulmonary bypass. , 2008, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[8]  P. Santamaria,et al.  Adenosine Deamination Sustains Dendritic Cell Activation in Inflammation1 , 2007, The Journal of Immunology.

[9]  G. Burnstock,et al.  Purine and pyrimidine receptors , 2007, Cellular and Molecular Life Sciences.

[10]  Alexander Drobyshevsky,et al.  A Model of Cerebral Palsy From Fetal Hypoxia-Ischemia , 2007, Stroke.

[11]  S. Ceruti,et al.  P1 receptors and cytokine secretion , 2007, Purinergic Signalling.

[12]  G. Cristalli,et al.  Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase. , 2006, Acta biochimica Polonica.

[13]  D. Souza,et al.  Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: Prevention by guanosine , 2005, Experimental Neurology.

[14]  R. Cunha,et al.  Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade , 2005, Purinergic Signalling.

[15]  Brandon K Harvey,et al.  Inosine Reduces Ischemic Brain Injury in Rats , 2005, Stroke.

[16]  D. Ferriero.  Neonatal brain injury. , 2004, The New England journal of medicine.

[17]  M. Teixeira,et al.  Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice , 2004, Inflammation Research.

[18]  W. Law,et al.  Macrophages are a source of extracellular adenosine deaminase‐2 during inflammatory responses , 2004, Clinical and experimental immunology.

[19]  S. Vannucci,et al.  Hypoxia–ischemia in the immature brain , 2004, Journal of Experimental Biology.

[20]  K. Nelson,et al.  Stroke in newborn infants , 2004, The Lancet Neurology.

[21]  N. Dale,et al.  Plasticity of purine release during cerebral ischemia: clinical implications? , 2003, Journal of cellular and molecular medicine.

[22]  J. Elias,et al.  Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. , 2003, The Journal of clinical investigation.

[23]  R. D. De Abreu,et al.  Purine enzymes in patients with rheumatoid arthritis treated with methotrexate , 2002, Annals of the rheumatic diseases.

[24]  S. Rivkees,et al.  A1 adenosine receptor activation induces ventriculomegaly and white matter loss , 2002, Neuroreport.

[25]  J. Wardas.  Neuroprotective role of adenosine in the CNS. , 2002, Polish journal of pharmacology.

[26]  J. Ribeiro,et al.  Activation of Synaptic NMDA Receptors by Action Potential-Dependent Release of Transmitter during Hypoxia Impairs Recovery of Synaptic Transmission on Reoxygenation , 2001, The Journal of Neuroscience.

[27]  S. Latini,et al.  Adenosine in the central nervous system: release mechanisms and extracellular concentrations , 2001, Journal of neurochemistry.

[28]  H. Koprowski,et al.  Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease , 2001, Multiple sclerosis.

[29]  T. S. Fröde,et al.  Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. , 2001, Mediators of inflammation.

[30]  B. Fredholm,et al.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Rathbone,et al.  Involvement of astrocytes in purine-mediated reparative processes in the brain , 2001, International Journal of Developmental Neuroscience.

[32]  D G Davies,et al.  Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  Alexandre de Mendonça,et al.  Adenosine: does it have a neuroprotective role after all? , 2000, Brain Research Reviews.

[34]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[35]  R. Berger,et al.  Perinatal brain injury , 2000, Journal of perinatal medicine.

[36]  S. Kobayashi,et al.  Stimulation of Expression for the Adenosine A2A Receptor Gene by Hypoxia in PC12 Cells , 1999, The Journal of Biological Chemistry.

[37]  J. Mallol,et al.  Adenosine Deaminase and A1 Adenosine Receptors Internalize Together following Agonist-induced Receptor Desensitization* , 1998, The Journal of Biological Chemistry.

[38]  Y. Okada,et al.  The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia—in vivo study , 1998, Brain Research.

[39]  M. Blackburn,et al.  Adenosine Deaminase-deficient Mice Generated Using a Two-stage Genetic Engineering Strategy Exhibit a Combined Immunodeficiency* , 1998, The Journal of Biological Chemistry.

[40]  B. Becher,et al.  Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis , 1997, Journal of Neuroimmunology.

[41]  A. Siegbahn,et al.  Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). , 1997, Journal of cell science.

[42]  J. Zweier,et al.  Adenosine Deaminase Inhibition Prevents Free Radical-mediated Injury in the Postischemic Heart (*) , 1996, The Journal of Biological Chemistry.

[43]  J. J. Moreno,et al.  Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application. , 1995, Biochemical pharmacology.

[44]  P. Di Iorio,et al.  Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes , 1994, Journal of neuroscience research.

[45]  W. Vermaak,et al.  Serum adenosine deaminase: isoenzymes and diagnostic application. , 1992, Clinical chemistry.

[46]  J. Luzio,et al.  Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses , 1987, Nature.

[47]  S. Sasagawa,et al.  Assay method for myeloperoxidase in human polymorphonuclear leukocytes. , 1983, Analytical biochemistry.

[48]  R. Christensen,et al.  Cellular and extracellular myeloperoxidase in pyogenic inflammation , 1982 .

[49]  E. Lewin,et al.  Electroshock Seizures in Mice: Effect on Brain Adenosine and Its Metabolites , 1981, Epilepsia.

[50]  J. Rice,et al.  The influence of immaturity on hypoxic‐ischemic brain damage in the rat , 1981, Annals of neurology.

[51]  M. Hershfield,et al.  Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts. , 1978, Cancer research.

[52]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[53]  J. Smyth,et al.  Role of adenosine deaminase in lymphocyte proliferation. , 1976, Clinical and experimental immunology.

[54]  Syed Jamal Mustafa,et al.  Latent adenosine deaminase in mouse brain. II. Purification and properties of mitochondrial and supernatant adenosine deaminases. , 1970, Biochimica et biophysica acta.

[55]  S. Klebanoff.  Myeloperoxidase: Contribution to the Microbicidal Activity of Intact Leukocytes , 1970, Science.

[56]  Syed Jamal Mustafa,et al.  Latent adenosine deaminase in mouse brain. I. Exposure and solubilization of the mitochondrial enzyme. , 1970, Biochimica et biophysica acta.

[57]  T. Gallart,et al.  Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alterations of the immune function. , 2007, Critical reviews in immunology.

[58]  I. Szelenyi,et al.  Measurement of MPO activity as model for detection of granulocyte infiltration in different tissues , 2005, Agents and Actions.

[59]  F. Ciruela,et al.  Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. , 2001, Molecular pharmacology.

[60]  T. Dunwiddie,et al.  The Role and Regulation of Adenosine in the Central Nervous System , 2022 .

[61]  B. Fredholm,et al.  Adenosine and brain ischemia. , 1992, Cerebrovascular and brain metabolism reviews.